Oral and topical antibiotics for clinically infected eczema in children: A pragmatic randomized controlled trial in ambulatory care

Annals of Family Medicine

Volumn 15, Issue 2, 2017, Pages 124-130

  Francis, Nick A ^a   Ridd, Matthew J ^b   Thomas Jones, Emma ^a   Butler, Christopher C ^c   Hood, Kerenza ^a   Shepherd, Victoria ^a   Marwick, Charis A ^d   Huang, Chao ^a   Longo, Mirella ^e   Wootton, Mandy ^f   Sullivan, Frank ^g  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

^e SWANSEA UNIVERSITY   (United Kingdom)

^f UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

Anti bacterial agents; Eczema; Infection

Indexed keywords

ANTIINFECTIVE AGENT; CORTICOSTEROID; FLUCLOXACILLIN; FUSIDIC ACID;

AMBULATORY CARE; CHILD; CUTANEOUS DRUG ADMINISTRATION; ECZEMA; FEMALE; HUMAN; INFANT; MALE; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED KINGDOM;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; ECZEMA; FEMALE; FLOXACILLIN; FUSIDIC ACID; HUMANS; INFANT; MALE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 85015172519     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.2038     Document Type: Article

References (35)

1. Hanifin JM, Reed ML;​Eczema Prevalence and Impact Working Group. A population-based survey of eczema prevalence in the United States. Dermatitis. 2007;18(2):82-91.
2. Emerson RM, Williams HC, Allen BR. What is the cost of atopic dermatitis in preschool children? Br J Dermatol. 2001;144(3):514-522.
3. Beattie PE, Lewis-Jones MS. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br J Dermatol. 2006;155(1):145-151.
4. NHS National Institute for Health Clinical Excellence (NICE). National Costing Report:​Atopic Eczema in Children. London, England:​ NICE; 2008.
5. Langan SM, Schmitt J, Williams HC, Smith S, Thomas KS. How are eczema ‘flares’ defined? A systematic review and recommendation for future studies. Br J Dermatol. 2014;170(3):548-556.
6. Aagaard L, Hansen EH. Adverse drug reactions reported for systemic antibacterials in Danish children over a decade. Br J Clin Pharmacol. 2010;70(5):765-768.
7. Totté JE, van der Feltz WT, Hennekam M, van Belkum A, van Zuuren EJ, Pasmans SG. Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis:​a systematic review and meta-analysis. Br J Dermatol. 2016;175(4):687-695.
8. Higaki S, Morohashi M, Yamagishi T, Hasegawa Y. Comparative study of staphylococci from the skin of atopic dermatitis patients and from healthy subjects. Int J Dermatol. 1999;38(4):265-269.
9. Birnie AJ, Bath-Hextall FJ, Ravenscroft JC, Williams HC. Interventions to reduce Staphylococcus aureus in the management of atopic eczema. Cochrane Database Syst Rev. 2008;(3):CD003871.
10. Bath-Hextall FJ, Birnie AJ, Ravenscroft JC, Williams HC. Interventions to reduce Staphylococcus aureus in the management of atopic eczema:​an updated Cochrane review. Br J Dermatol. 2010;163(1): 12-26.
11. Williams HC, Burney PG, Hay RJ, et al. The U.K. Working Party’s Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol. 1994;​ 131(3):383-396.
12. Charman CR, Venn AJ, Williams HC. The patient-oriented eczema measure:​development and initial validation of a new tool for measuring atopic eczema severity from the patients’ perspective. Arch Dermatol. 2004;140(12):1513-1519.
13. Schram ME, Spuls PI, Leeflang MMG, Lindeboom R, Bos JD, Schmitt J. EASI, (objective) SCORAD and POEM for atopic eczema:​ responsiveness and minimal clinically important difference. Allergy. 2012;67(1):99-106.
14. Gaunt DM, Metcalfe C, Ridd M. The Patient-Oriented Eczema Measure in young children:​responsiveness and minimal clinically important difference. Allergy. 2016;71(11):1620-1625.
15. Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M;​ EASI Evaluator Group. The eczema area and severity index (EASI):​ assessment of reliability in atopic dermatitis. Exp Dermatol. 2001;​ 10(1):11-18.
16. Lewis-Jones MS, Finlay AY, Dykes PJ. The Infants’ Dermatitis Quality of Life Index. Br J Dermatol. 2001;144(1):104-110.
17. Lewis-Jones MS, Finlay AY. The Children’s Dermatology Life Quality Index (CDLQI):​initial validation and practical use. Br J Dermatol. 1995;132(6):942-949.
18. Lawson V, Lewis-Jones MS, Finlay AY, Reid P, Owens RG. The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire. Br J Dermatol. 1998;138(1):107-13.
19. Stevens KJ, Brazier JE, McKenna SP, Doward LC, Cork MJ. The development of a preference-based measure of health in children with atopic dermatitis. Br J Dermatol. 2005;153(2):372-377.
20. Joint Formulary Committee. British National Formulary (BNF) 69. London, England:​Pharmaceutical Press;​2015.
21. Keogh-Brown MR, Bachmann MO, Shepstone L, et al. Contamination in trials of educational interventions. Health Technol Assess. 2007;11(43):iii-ix–107,ix-107.
22. Francis NA, Ridd MJ, Thomas-Jones E, et al.;​CREAM team. A randomised placebo-controlled trial of oral and topical antibiotics for children with clinically infected eczema in the community:​the ChildRen with Eczema, Antibiotic Management (CREAM) study. Health Technol Assess. 2016;20(19):i-xxiv,1-84.
23. Ridd MJ, Garfield K, Gaunt DM, et al. Choice of Moisturiser for Eczema Treatment (COMET): feasibility study of a randomised controlled parallel group trial in children recruited from primary care. BMJ Open. 2016 Nov 16;6(11):e012021.
24. Santer M, Rumsby K, Ridd MJ, et al. Bath additives for the treatment of childhood eczema (BATHE): protocol for multicentre parallel group randomized trial. BMJ Open. 2015 Nov 1;5(10):e009575.
25. Weinberg E, Fourie B, Allmann B, Toerien A. The use of cefadroxil in superinfected atopic dermatitis. Curr Thera Res. 1992;52(5):671-676.
26. Wachs GN, Maibach HI. Co-operative double-blind trial of an antibiotic/corticoid combination in impetiginized atopic dermatitis. Br J Dermatol. 1976;95(3):323-328.
27. Larsen FS, Simonsen L, Melgaard A, Wendicke K, Henriksen AS. An efficient new formulation of fusidic acid and betamethasone 17-valerate (fucicort lipid cream) for treatment of clinically infected atopic dermatitis. Acta Derm Venereol. 2007;87(1):62-68. 10.2340/00015555-0174.
28. Ewing CI, Ashcroft C, Gibbs AC, Jones GA, Connor PJ, David TJ. Flucloxacillin in the treatment of atopic dermatitis. Br J Dermatol. 1998;​ 138(6):1022-1029.
29. Boguniewicz M, Sampson H, Leung SB, Harbeck R, Leung DY. Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis. J Allergy Clin Immunol. 2001;​ 108(4):651-652.
30. Canpolat F, Erkoçoğlu M, Tezer H, Kocabaş CN, Kandi B. Hydrocortisone acetate alone or combined with mupirocin for atopic dermatitis in infants under two years of age - a randomized double blind pilot trial. Eur Rev Med Pharmacol Sci. 2012;16(14):1989-1993.
31. Ravenscroft JC, Layton A, Barnham M. Observations on high levels of fusidic acid resistant Staphylococcus aureus in Harrogate, North Yorkshire, UK. Clin Exp Dermatol. 2000;25(4):327-330.
32. Hon KL, Wang SS, Lee KKC, Lee VWY, Leung TF, Ip M. Combined antibiotic/corticosteroid cream in the empirical treatment of moderate to severe eczema:​friend or foe? J Drugs Dermatol. 2012;11(7):861-864.
33. Heng YK, Tan KT, Sen P, et al. Staphylococcus aureus and topical fusidic acid use:​results of a clinical audit on antimicrobial resistance. Int J Dermatol. 2013;52(7):876-881.
34. Maudsley J, Stone SP, Kibbler CC, et al. The community prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in older people living in their own homes:​implications for treatment, screening and surveillance in the UK. J Hosp Infect. 2004;57(3):258-262.
35. Nilsson EJ, Henning CG, Magnusson J. Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. J Am Acad Dermatol. 1992;27(1):29-34.